A report from Pharmaceutical Commerce forecasted a $15 billion spend on logistics for cold chain products in 2018, and is set for further growth to over $18.6 billion by 2022.
The CCGF team surveyed pharma executives from companies like Gilead Sciences, Roche, AstraZeneca, Sanofi, Genetech, Abbvie, Mylan, Eli Lilly and more to get their thoughts on whether the current cold chain logistics infrastructure is adequately equipped to support both existing products and incoming cryogenic and ultrafrozen products.
See what they had to say in this exclusive report.
If you would like a copy sent directly to you, please contact us here.
Please note: That all fields marked with an asterisk (*) are required.